menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Research Updates on Postprandial Dyslipidemia Treatment

Research Updates on Postprandial Dyslipidemia Treatment
RestartResume
Postprandial hypertriglyceridemia occurs when the rapid absorption of dietary fat (in the form of chylomicron triglycerides) overwhelms the body's ...
  • Overview

    Postprandial hypertriglyceridemia occurs when the rapid absorption of dietary fat (in the form of chylomicron triglycerides) overwhelms the body's ability to clear plasma triglyceride. In its most severe form, postprandial hypertriglyceridemia can lead to chylomicronemia and a greatly increased risk of acute, life-threatening pancreatitis. Joining host Dr. Alan Brown to talk about this condition and a trial drug treatment in research and development is Dr. Dan Meyers, one of the top winners in the Abstracts Program of the National Lipid Association's Annual Scientific Sessions. Dr. Meyers is currently a Translational Medicine Expert with Novartis Institutes of Biomedical Research (NIBR) in Cambridge, MA. While at NIBR, he has designed and executed first-in-human, proof of concept, and mechanistic studies with novel compounds intended for the treatment of dyslipidemia, diabetes and related metabolic disease.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 12/12/19